Application Sponsors
ANDA 208317 | FRESENIUS KABI USA | |
Marketing Status
Application Products
001 | INJECTABLE;SUBCUTANEOUS | EQ 30MG BASE/3ML (EQ 10MG BASE/ML) | 0 | ICATIBANT ACETATE | ICATIBANT ACETATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2020-06-18 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
FRESENIUS KABI USA
cder:Array
(
[0] => Array
(
[ApplNo] => 208317
[companyName] => FRESENIUS KABI USA
[docInserts] => ["",""]
[products] => [{"drugName":"ICATIBANT ACETATE","activeIngredients":"ICATIBANT ACETATE","strength":"EQ 30MG BASE\/3ML (EQ 10MG BASE\/ML)","dosageForm":"INJECTABLE;SUBCUTANEOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"06\/18\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2020-06-18
)
)